# Comparing Angiomax to Heparin With Protamine in Patients Undergoing Cardiopulmonary Bypass (CPB)

> **NCT00079586** · PHASE3 · COMPLETED · sponsor: **The Medicines Company** · enrollment: 150 (actual)

## Conditions studied

- Cardiovascular Disease
- Coronary Artery Bypass Surgery

## Interventions

- **DRUG:** Heparin
- **DRUG:** Bivalirudin

## Key facts

- **NCT ID:** NCT00079586
- **Lead sponsor:** The Medicines Company
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-04
- **Primary completion:** —
- **Final completion:** 2004-11
- **Target enrollment:** 150 (ACTUAL)
- **Last updated:** 2012-01-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00079586

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00079586, "Comparing Angiomax to Heparin With Protamine in Patients Undergoing Cardiopulmonary Bypass (CPB)". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00079586. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*